European Archives - Page 771 of 996 - European Medical Journal

The Potential of Immune Cells to Treat Allergy and Infection

SUCCESSFUL allergy and infection therapies may be possible following recent insights into the development and function of newly discovered Type 1…

Reducing the Harmful Effects of Immune Cells

DISRUPTION of a key enzyme involved in immune cell-mediated damage has been researchers’ focus, in the hope of discovering a novel treatment target for a…

Mesothelioma: A Dormant Threat

The industrialised world is truly a marvel; through years of innovation and invention, society has been rewarded with extreme technological advances.

Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse

Immatics announced enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101.

Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency

London, UK, 22 August, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies…

Action-Packed August

Here in the EMJ offices, August would best be described by the team as a whirlwind, with not one, but six brand new publications ready for you to choose…

Kale Increases Cognitive Concentration

LUTEIN, a pigment found in kale, spinach, avocados, and eggs, may work to rejuvenate cognitive function, according to a study from the University of…

Biological Age Accelerated by Bipolar Disorder

RESEARCH conducted at Kings College London, London, UK and Icahn School of Medicine, Mount Sinai, New York City, New York, USA has shown a link between…

Introducing EMJ Reproductive Health 3.1

United Kingdom, August 17, 2017: A warm welcome to the 2017 EMJ Reproductive Health eJournal! This instalment gives a complete review of…

Can A Second Dose of Kisspeptin Safely Improve Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome?

Kisspeptin is a novel neuropeptide that came to prominence in the field of fertility in 2003, when it was discovered that genetic mutations causing…